For instance, the previous study showed that inhibition of PRMT6 using pharmacological and genetic interventions significantly prevents hair cells from aminoglycoside- and cisplatin-induced damage by decreasing ROS generation and results in preservation of mitochondrial function, supporting the notion that targeting mitochondria might improve protection against ototoxicity-induced hearing loss [21]. This evidence concerns the gene PRMT6 and hearing loss disorder.